6 Months of "Temporary" Support by Levitronix Left Ventricular Assist Device

Alessandro Barbone, Pietro Giorgio Malvindi, Robert A. Sorabella, Graziano Cortis, Paolo F. Tosi, Alessio Basciu, Pietro Ferrara, Giuseppe Raffa, Enrico Citterio, Fabrizio Settepani, Diego Ornaghi, Giuseppe Tarelli, Ettore Vitali

Research output: Contribution to journalArticlepeer-review


An otherwise healthy 47-year-old man presented to the emergency department in cardiogenic shock after suffering a massive myocardial infarction due to left main occlusion. He was initially supported by extracorporeal membrane oxygenation and subsequently was converted to paracorporeal support with a Levitronix left ventricular assist device. He experienced multiple postoperative complications including renal failure, respiratory failure, retroperitoneal hematoma requiring suspension of anticoagulation, and fungal bloodstream infection precluding transition to an implantable device. He was reconditioned and successfully underwent orthotopic heart transplant 183 days after presentation. A discussion of the relevant issues is included.

Original languageEnglish
Pages (from-to)639-642
Number of pages4
JournalArtificial Organs
Issue number7
Publication statusPublished - Jul 2012


  • Candida parapsilosis
  • Extracorporeal membrane oxygenation
  • Fungal infection
  • Left ventricular assist device
  • Mechanical support
  • Multiorgan failure
  • Paracorporeal device

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)


Dive into the research topics of '6 Months of "Temporary" Support by Levitronix Left Ventricular Assist Device'. Together they form a unique fingerprint.

Cite this